在接受化疗的儿童中评估口腔并发症:一项观察性研究
P Ambati1, Virat Galhotra, Sunil Natha Jondhale
1Department of Dentistry, AIIMS, Raipur, Chhattisgarh, India.
Journal of the Indian Society of Pedodontics and Preventive Dentistry
|September 9, 2024
概括
接受化疗的儿童癌症患者经历了严重的口腔健康问题,包括粘膜炎和脏增加. 虽然粘膜炎有所改善,但持续的口腔护理对于患有癌症的儿童至关重要.
科学领域:
- 儿科瘤学 儿科瘤学
- 口腔医学是指口腔医学.
- 临床研究 临床研究
背景情况:
- 儿童癌症的化疗对口腔健康构成重大风险.
- 在接受治疗的儿科癌症患者中,口腔并发症很常见.
研究的目的:
- 评估接受化疗的癌症儿童口腔并发症的患病率和进展情况.
- 评估化疗治疗期间口腔健康状况随时间变化的情况.
主要方法:
- 在印度中部44名儿科癌症患者的前性观察性研究.
- 基线口腔检查和3-12个月的随访,包括世卫组织粘膜炎分级.
- 对人口统计,病史,口腔卫生,病变和血液计数进行分析.
主要成果:
- 急性淋巴细胞白血病 (ALL) 是最常见的诊断.
- 粘膜炎的患病率从基线时的56.8%下降到第二次随访时的13.3%.
- 脏经验得分增加,而牙炎症得分随着时间的推移而下降.
结论:
- 患有癌症的儿童在化疗期间面临各种口腔并发症,趋势各不相同.
- 尽管粘膜炎有所改善,但牙等持续问题需要有针对性的口腔护理干预.
- 预防性口腔保健策略对于管理这个脆弱的儿科群体的口腔健康至关重要.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
Assessment of the Mouth
148
A thorough mouth assessment, including inspection and palpation of the lips, gums, tongue, tonsils, uvula, and pharynx, is crucial in detecting potential health issues. Diseases ranging from oral cancer to systemic conditions like diabetes could be identified early through careful oral examination. This article provides a detailed guide on conducting a comprehensive mouth assessment.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
148
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
154
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
154
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
237
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
237
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
204
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
204
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


